Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 02:10 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Phase II RCT to Assess Efficacy of Intravenous Administration of Oxytocin in Patients Affected by COVID-19
NCT04386447 · Azienda Ospedaliero-Universitaria di Parma · PHASE2 · withdrawn · last registry update 2021-01-14 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “The study was not approved by the Italian Medicines Agency (AIFA).” | – | Registry record, Azienda Ospedaliero-Universitaria di Parma |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against OXTR within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2021-11-17Results posted on the registry: Levo Therapeutics, Inc., 3.2 mg intranasal carbetocin + 9.6 mg intranasal carbetocin (NCT03649477)
- 2021-10-26Phase 3 first posted: Central Institute of Mental Health, Mannheim, Oxytocin nasal spray + Naltrexone Pill (NCT05093296)
- 2021-09-02Phase 3 first posted: University Hospital, Toulouse, Follow-up study of the treated cohort (NCT05032326)
- 2021-08-30Phase 3 first posted: Stanford University, Calcium chloride + Saline placebo (NCT05027048)
- 2021-07-02Phase 3 first posted: University Hospital, Tours, Prostaglandins + Oxytocin (NCT04949633)
- 2021-05-26Phase 3 first posted: Memorial University of Newfoundland, 24-IU oxytocin + 48-IU oxytocin (NCT04903002)
- 2020-11-16Results posted on the registry: Holland Bloorview Kids Rehabilitation Hospital, Intranasal Oxytocin + Placebo (NCT01908205)
- 2020-06-11Phase 3 first posted: KK Women's and Children's Hospital, Tranexamic acid + Normal saline (NCT04427618)
- 2020-03-11Phase 3 first posted: University Hospital, Bordeaux, Tranexamic Acid / Sodium chloride (NCT04304625)
- 2020-02-25Phase 3 first posted: University Hospital, Toulouse, OT + Placebo comparator (NCT04283578)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision